CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
41.93
-0.52 (-1.22%)
At close: Jan 8, 2026, 4:00 PM EST
42.01
+0.08 (0.19%)
After-hours: Jan 8, 2026, 7:05 PM EST
CG Oncology Employees
CG Oncology had 113 employees as of December 31, 2024. The number of employees increased by 52 or 85.25% compared to the previous year.
Employees
113
Change (1Y)
52
Growth (1Y)
85.25%
Revenue / Employee
$19,239
Profits / Employee
-$1,340,566
Market Cap
3.38B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 113 | 52 | 85.25% |
| Dec 31, 2023 | 61 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CGON News
- 2 days ago - CG Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 16 days ago - CG Oncology Undervalued Going Into A Busy 2026 - Seeking Alpha
- 4 weeks ago - New Cretostimogene Grenadenorepvec Data Highlight its Potential to Become the Backbone Therapy for High-Risk Non-Muscle Invasive Bladder Cancer - GlobeNewsWire
- 6 weeks ago - CG Oncology Announces New Board Member and Board Transition - GlobeNewsWire
- 7 weeks ago - CG Oncology Reports Third Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 3 months ago - CG Oncology: Upgraded, Rising, But Should We Still Be Optimistic? - Seeking Alpha
- 4 months ago - CG Oncology, Inc. (CGON) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 4 months ago - CG Oncology Stock Signals Bullish Momentum Ahead - Benzinga